×
戻る Agenda
S33 : Current Status and Issues of Pharmaceutical Venture Support Based on Efforts to Improve Pharmaceutical Regulations (RA)
Session Chair(s)
Yasuko Terao, PHD
Head, External Scientific Engagement, R&D Japan Region,, Takeda Pharmaceutical Co., Ltd., Japan
Speaker(s)
Toshio Fujimoto
President, Ipark institute, Japan
Tadahisa Kagimoto
Chairman and CEO, Healios K.K, Japan
Tadayuki Mizutani
Pharmaceutical Vencure promotion and Medical information Planning Division , MHLW Medical Policy Bureau, Japan
Jun Kusunoki
Innovation Early Innovation partnaring, Sinior Director, Japan countory lead, Jhonson and Jhonson innovation, Japan